Triclabendazole: Potent Anthelmintic for Veterinary Medicine and Pharmaceutical Intermediates
Discover the exceptional efficacy of Triclabendazole, a leading anthelmintic for livestock and a vital pharmaceutical intermediate.
Get a Quote & SampleProduct Core Value
Triclabendazole
Triclabendazole is a premier benzimidazole anthelmintic drug, critically important for treating a wide spectrum of parasitic worm infestations. It is extensively used in veterinary medicine, particularly for sheep, goats, and cattle, offering a reliable solution against internal parasites.
- Ensure optimal animal health by using Triclabendazole for sheep and goats, a robust solution for parasitic worm infections.
- Source high-purity Triclabendazole powder with a purity of >99%, meeting stringent pharmaceutical intermediate standards.
- Benefit from the compound's reliable mechanism of action as an anthelmintic flukicide, proven effective in livestock.
- Invest in quality with ISO 9001 certification and USP grade assurance for your pharmaceutical needs.
Key Advantages
Veterinary Efficacy
Leverage Triclabendazole's proven efficacy in veterinary medicine to combat prevalent parasitic worm issues in livestock, ensuring healthier animals.
Pharmaceutical Grade Purity
Utilize our high-purity Triclabendazole powder (>99%) as a reliable pharmaceutical intermediate, essential for drug formulation.
Broad-Spectrum Action
Triclabendazole offers broad-spectrum anthelmintic activity, making it a versatile choice for various parasitic worm treatments.
Key Applications
Veterinary Medicine
Administer Triclabendazole orally for effective treatment of fascioliasis and other worm infestations in animals like sheep and cattle.
Pharmaceutical Intermediates
Source high-quality Triclabendazole powder as a crucial intermediate for the synthesis of pharmaceutical products.
Animal Health Products
Integrate Triclabendazole into animal health formulations to combat parasitic diseases and improve livestock productivity.
Research and Development
Utilize Triclabendazole in R&D for developing new antiparasitic treatments and veterinary pharmaceuticals.